TSPAN8 and ovarian carcinoma: TSPAN8-LEL recognized antibody shows inhibition of ovarian cancer cell metastasis both ex vivo and in vivo without severe in vitro cytotoxicity or in vivo nephrotoxicity and hepatotoxicity (92).